| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hyperion Defi, Inc. (HYPD) has 7 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. HYPD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.39M | $5.14M | +8.0K | |
| CFO | 327.9K | $1.22M | - | |
| Dir | 111.9K | $415.3K | - | |
| Dir | 88.0K | $326.5K | - | |
| Other | 75.0K | $278.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | Strahlman Ellen R66 | Director | Buy | 10,000 | $3.10 | $30,976.00 | +23.2% | -40.1% | -75.7% | |
| May 15, 2023 | Mather Charles E IV | Director | Buy | 4,000 | $3.39 | $13,560.00 | +5.7% | -38.1% | -74.9% | |
| May 1, 2023 | Ianchulev Tsontcho77 | Director | Sell | 90,000 | $5.50 | $495,000.00 | -21.4% | -59.7% | -85.8% | |
| Apr 27, 2023 | Ianchulev Tsontcho77 | Director | Sell | 60,000 | $5.00 | $300,000.00 | -12.5% | -59.0% | -87.4% | |
| Apr 14, 2023 | Ianchulev Tsontcho77 | Director | Sell | 40,000 | $4.50 | $180,000.00 | -7.7% | -45.4% | -88.6% | |
| Apr 11, 2023 | Ianchulev Tsontcho77 | Director | Sell | 40,000 | $4.00 | $160,000.00 | -7.1% | -37.7% | -86.7% | |
| Mar 31, 2023 | Ianchulev Tsontcho77 | Director | Sell | 40,000 | $3.50 | $140,000.00 | -6.7% | -34.0% | -72.1% | |
| Dec 30, 2022 | Grant Stuart M. | 10% Owner | Buy | 21,753 | $1.50 | $32,629.50 | +0.4% | +95.1% | +27.6% | |
| Dec 30, 2022 | Rowe Michael M | Chief Executive Officer | Buy | 10,000 | $1.54 | $15,400.00 | +181.8% | +95.1% | +27.6% | |
| Aug 31, 2022 | Strahlman Ellen R66 | Director | Buy | 21,361 | $1.61 | $34,445.69 | +24.4% | +20.9% | +16.0% |